|
|
 |
|
Total Number of Holdings (excluding cash): 50
| Exact Sciences Corporation |
EXAS |
30063P105 |
684 |
$70,691.40 |
3.43% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
705 |
$66,129.00 |
3.21% |
| Align Technology, Inc. |
ALGN |
016255101 |
317 |
$59,919.34 |
2.90% |
| Penumbra, Inc. |
PEN |
70975L107 |
153 |
$52,371.90 |
2.54% |
| Hoya Corporation |
7741.JP |
J22848105 |
294 |
$52,087.83 |
2.52% |
| The Cooper Companies, Inc. |
COO |
216648501 |
583 |
$48,925.36 |
2.37% |
| Masimo Corporation |
MASI |
574795100 |
276 |
$48,410.40 |
2.35% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
539 |
$46,990.02 |
2.28% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
1,917 |
$46,903.38 |
2.27% |
| Alcon Inc. |
ALC.SW |
H01301128 |
552 |
$46,247.76 |
2.24% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
93 |
$46,151.25 |
2.24% |
| Waters Corporation |
WAT |
941848103 |
148 |
$45,470.04 |
2.20% |
| DexCom, Inc. |
DXCM |
252131107 |
612 |
$45,153.36 |
2.19% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
1,452 |
$45,091.30 |
2.19% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
562 |
$45,049.92 |
2.18% |
| Hologic, Inc. |
HOLX |
436440101 |
589 |
$44,440.05 |
2.15% |
| Revvity, Inc. |
RVTY |
714046109 |
452 |
$43,206.68 |
2.09% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
369 |
$42,469.87 |
2.06% |
| Stryker Corporation |
SYK |
863667101 |
109 |
$42,185.18 |
2.04% |
| Steris Plc |
STE |
G8473T100 |
169 |
$41,873.13 |
2.03% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
421 |
$41,885.29 |
2.03% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
2,785 |
$41,304.71 |
2.00% |
| Medtronic Plc |
MDT |
G5960L103 |
418 |
$41,005.80 |
1.99% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
31 |
$41,077.79 |
1.99% |
| Teleflex Incorporated |
TFX |
879369106 |
334 |
$41,058.62 |
1.99% |
| Danaher Corporation |
DHR |
235851102 |
197 |
$40,582.00 |
1.97% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
2,263 |
$40,025.94 |
1.94% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
184 |
$38,699.70 |
1.88% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
505 |
$38,632.50 |
1.87% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
76 |
$38,652.08 |
1.87% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
152 |
$38,190.00 |
1.85% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
147 |
$38,009.63 |
1.84% |
| Becton, Dickinson and Company |
BDX |
075887109 |
214 |
$37,779.56 |
1.83% |
| ResMed Inc. |
RMD |
761152107 |
147 |
$37,836.33 |
1.83% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
134 |
$37,465.06 |
1.82% |
| Baxter International Inc. |
BAX |
071813109 |
1,817 |
$35,776.73 |
1.73% |
| BioMerieux |
BIM.FP |
F1149Y232 |
300 |
$35,435.86 |
1.72% |
| Amplifon SpA |
AMP.IM |
T0388E118 |
2,331 |
$35,296.44 |
1.71% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
729 |
$35,130.77 |
1.70% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,129 |
$34,799.21 |
1.69% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
455 |
$34,565.47 |
1.68% |
| Abbott Laboratories |
ABT |
002824100 |
301 |
$34,350.12 |
1.67% |
| Agilent Technologies, Inc. |
A |
00846U101 |
292 |
$34,505.64 |
1.67% |
| Boston Scientific Corporation |
BSX |
101137107 |
418 |
$31,859.96 |
1.54% |
| Terumo Corporation |
4543.JP |
J83173104 |
2,460 |
$31,654.02 |
1.53% |
| Insulet Corporation |
PODD |
45784P101 |
127 |
$31,172.15 |
1.51% |
| Olympus Corporation |
7733.JP |
J61240107 |
3,240 |
$30,037.50 |
1.46% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
3,234 |
$29,812.38 |
1.45% |
| Cochlear Limited |
COH.AU |
Q25953102 |
215 |
$29,763.95 |
1.44% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
805 |
$24,167.07 |
1.17% |
| US Dollar |
$USD |
|
2,655 |
$2,654.90 |
0.13% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|